Form 4 for AGL agilon health, inc.
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001209191-23-011763 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-22 | 2023-02-17 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,078 | 1,078 | New | $0 |
| D | 2023-02-22 | 2023-02-17 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +11.1K | 11.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-17 | A | A | 1,078 | $0.00 | 1,078 | D | — | — | (F1) Restricted stock units that vest in full on February 17, 2024, subject to continued service as a director. |
| 2 | Derivative | Options (Rights to Buy) | 2023-02-17 | A | A | 11,104 | $0.00 | 11,104 | D | $22.79 · — to 2033-02-17 | 11,104 Common Stock | (F2) Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director. |